Free clinical calculators and scores for physicians and medical students · Browse all calculators
← All calculators and scores
Infectious Diseases

Bristol Stool Scale (Types 1-7)

Classification of stool consistency (types 1–7)

Primary source: Lewis SJ, Heaton KW. Scand J Gastroenterol 1997; 32(9): 920-924

Last clinical review: April 28, 2026

Online calculation

Stool type

About this score

The Bristol Stool Form Scale (Heaton KW et al., Scand J Gastroenterol 1997) is a standardized visual-descriptive scale developed at the University of Bristol to assess stool form and consistency. It is used in gastroenterology, infectious disease medicine, and general practice to objectify patient-reported symptoms.

The scale comprises 7 types: type 1 - separate hard lumps ("nuts", severe constipation); type 2 - sausage-shaped but lumpy (constipation); type 3 - sausage-shaped with cracks on the surface (normal); type 4 - smooth, soft, like a sausage or snake (normal, optimal); type 5 - soft blobs with clear-cut edges (tendency toward diarrhea); type 6 - fluffy pieces with ragged edges (diarrhea); type 7 - watery, no solid pieces (severe diarrhea).

Used in the diagnosis of IBS (classification into IBS-C/IBS-D/IBS-M per Bristol), assessment of laxative and antidiarrheal efficacy, severity assessment of infectious diarrhea, and monitoring of patients with diverticulosis, CKD, or in palliative care. The Bristol scale is included in the Rome IV criteria for IBS as a standard tool for documenting stool form.

When to use

Parameters in detail

Stool type

Stool type is determined visually or from patient report using an illustrated chart of the scale. Documented as "Bristol type 3", etc.

Clinical example

Case

Woman, 38 years old, with abdominal pain and altered bowel habits for one year. Bowel movements 4-5 times per week, Bristol type 1-2 (hard lumps, like nuts, or lumpy sausage-shaped stool), often with straining. Pain decreases after defecation.

Calculation

Bristol 1-2 — predominance of hard, formed stool.

Interpretation and management

IBS with constipation (IBS-C) per Rome IV criteria (≥25% of bowel movements Bristol 1-2 and <25% Bristol 6-7). Management: exclude red flags (weight loss, blood in stool, nocturnal symptoms, family history of colorectal cancer, especially in patients >45 years), CBC and metabolic panel, CRP, fecal calprotectin, TSH. After excluding organic disease: diet (FODMAP restriction for 4-6 weeks), osmotic laxatives (polyethylene glycol), and if response is inadequate, linaclotide or prucalopride. Psychotherapy (CBT) has an evidence base in IBS-C.

Limitations and cautions

Frequently asked questions

What is considered "normal"?
Bristol types 3-4 are normal. Type 4 ("sausage or snake") is optimal. One or two episodes of an atypical type per week are not pathological.
What is the Bristol type in infectious diarrhea?
Usually type 6-7 (mushy or watery). A trend from 7→6→5→4 is a marker of recovery.
Can it be used in children?
Applicable in children over 5 years. For infants and younger children, an adapted scale exists — the Brussels Infant and Toddler Stool Scale (BITSS).
How should a stool diary be used?
The patient records each bowel movement (date, time, Bristol type, presence of blood/mucus) for 1-2 weeks. This objectifies complaints and helps assess treatment efficacy.

All clinical calculators in one place

Validated scores and formulas with full interpretation, clinical examples and source references. Open access, no registration required.

65+ calculators · scores and formulas · interpretation with management notes

АА
Aleksandr A. Aulov Physician, internal medicine, Sechenov School — independent medical education platform. Calculators are compiled from the original publications and current clinical guidelines. Interpretation thresholds follow the source study unless stated otherwise.
This calculator is intended for healthcare professionals. Do not use it for self-diagnosis or self-treatment. Management decisions are made by the treating clinician based on the full clinical picture of the individual patient.